Nike Shares Hit Lowest Point in a Year Amid Demand Concerns

Nike shares fall to a new low as investor anxiety over soft demand and a strategic overhaul grows. Analysts show mixed views ahead of the crucial Q3 earnings report.

The world's largest sportswear manufacturer continues to face significant headwinds in the equity markets. On Friday, Nike's stock closed at a new 12-month low, reflecting persistent investor anxiety over soft global consumer demand. This decline occurs as CEO Elliott Hill attempts to steer the company through a strategic overhaul, with analysts showing diverging opinions ahead of the imminent quarterly earnings release.

A Convergence of Pressures Weighs on Performance

Several interrelated challenges are driving the stock's sustained weakness. The company's core operations are contending with shifting consumer preferences and ongoing supply chain disruptions. Broader macroeconomic uncertainty and geopolitical tensions are further suppressing purchasing sentiment across the global retail and apparel sector. This difficult environment is clearly illustrated in the share price performance: Nike equity has shed nearly 16% of its value since the start of the year, culminating in a Friday closing price of 45.41 euros—marking its lowest point over the past twelve months.

Divergent Views from Market Experts

With sales momentum under pressure, financial institutions are recalibrating their forecasts, resulting in a wide spectrum of assessments:

• Jefferies: Maintains a "Buy" rating with a price target of $110.
• BTIG: Also recommends "Buy," setting a target of $90.
• Stifel: Adopts a more cautious "Hold" stance with a $65 target.
• UBS: Rates the stock "Neutral" and has recently lowered its target.

The substantial variance in these price objectives highlights the market's uncertainty regarding the timeline for the company's corrective strategies to yield tangible results.

Upcoming Quarterly Report in Focus

All attention now turns to the end of the month for a concrete update on Nike's operational health. The firm is scheduled to publish its results for the third fiscal quarter of 2026 on March 31. This report will deliver crucial data indicating whether the strategic pivot initiated by CEO Elliott Hill in October 2024—known internally as the "Swoosh Pivot"—is beginning to generate measurable improvements in revenue growth. Accompanying the earnings, a regular quarterly dividend of $0.41 per share is set for distribution on April 1.